380 related articles for article (PubMed ID: 20022940)
21. Paraoxonase and arylesterase activities in patients with papillary thyroid cancer.
Korkmaz H; Tabur S; Özkaya M; Aksoy N; Yildiz H; Akarsu E
Scand J Clin Lab Invest; 2015 May; 75(3):259-64. PubMed ID: 25723374
[TBL] [Abstract][Full Text] [Related]
22. Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases.
Castellazzi M; Trentini A; Romani A; Valacchi G; Bellini T; Bonaccorsi G; Fainardi E; Cavicchio C; Passaro A; Zuliani G; Cervellati C
Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):356-363. PubMed ID: 27312742
[TBL] [Abstract][Full Text] [Related]
23. Changes of serum paraoxonase (an HDL-cholesterol-associated lipophilic antioxidant) and arylesterase activities in severe preeclamptic women.
Kumru S; Aydin S; Gursu MF; Ozcan Z
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):177-81. PubMed ID: 15140512
[TBL] [Abstract][Full Text] [Related]
24. Serum paraoxonase and arylesterase values as antioxidants in healthy premature infants at fasting and posprandial times.
Kahveci H; Laloglu F; Kilic O; Ciftel M; Yildirim A; Orbak Z; Ertekin V; Laloglu E
Eur Rev Med Pharmacol Sci; 2015 May; 19(10):1761-5. PubMed ID: 26044217
[TBL] [Abstract][Full Text] [Related]
25. Serum paraoxonase, arylesterase activity and oxidative status in patients with obstructive sleep apnea syndrome (OSAS).
Baysal E; Taysi S; Aksoy N; Uyar M; Celenk F; Karatas ZA; Tarakcioglu M; Bilinç H; Mumbuç S; Kanlikama M
Eur Rev Med Pharmacol Sci; 2012 Jun; 16(6):770-4. PubMed ID: 22913209
[TBL] [Abstract][Full Text] [Related]
26. Assessment of the serum paraoxonase activity and oxidant/antioxidant status in patients with recurrent aphthous stomatitis.
Bilgili SG; Ozkol H; Takci Z; Ozkol HU; Karadag AS; Aslan M
Int J Dermatol; 2013 Oct; 52(10):1259-64. PubMed ID: 23834345
[TBL] [Abstract][Full Text] [Related]
27. Paraoxonase (PON)-1 activity in overweight and obese children and adolescents: association with obesity-related inflammation and oxidative stress.
Krzystek-Korpacka M; Patryn E; Hotowy K; Czapińska E; Majda J; Kustrzeba-Wójcicka I; Noczyńska A; Gamian A
Adv Clin Exp Med; 2013; 22(2):229-36. PubMed ID: 23709379
[TBL] [Abstract][Full Text] [Related]
28. 12 weeks' aerobic and resistance training without dietary intervention did not influence oxidative stress but aerobic training decreased atherogenic index in middle-aged men with impaired glucose regulation.
Venojärvi M; Korkmaz A; Wasenius N; Manderoos S; Heinonen OJ; Lindholm H; Aunola S; Eriksson JG; Atalay M
Food Chem Toxicol; 2013 Nov; 61():127-35. PubMed ID: 23623841
[TBL] [Abstract][Full Text] [Related]
29. Serum paraoxonase and arylesterase activities in metabolic syndrome in Zahedan, southeast Iran.
Hashemi M; Kordi-Tamandani DM; Sharifi N; Moazeni-Roodi A; Kaykhaei MA; Narouie B; Torkmanzehi A
Eur J Endocrinol; 2011 Feb; 164(2):219-22. PubMed ID: 21059866
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of paraoxonase and arylesterase activities in patients with irritable bowel syndrome.
Oran M; Tulubas F; Mete R; Aydin M; Sarikaya HG; Gurel A
J Pak Med Assoc; 2014 Jul; 64(7):820-2. PubMed ID: 25255593
[TBL] [Abstract][Full Text] [Related]
31. Serum paraoxonase/arylesterase activity and oxidative stress status in children with metabolic syndrome.
Eren E; Abuhandan M; Solmaz A; Taşkın A
J Clin Res Pediatr Endocrinol; 2014 Sep; 6(3):163-8. PubMed ID: 25241610
[TBL] [Abstract][Full Text] [Related]
32. Serum paraoxonase/arylesterase activities in phenylketonuric patients on diet.
Schulpis KH; Bartzeliotou A; Tsakiris S; Gounaris A; Papassotiriou I
Eur J Clin Nutr; 2007 Jun; 61(6):803-8. PubMed ID: 17203019
[TBL] [Abstract][Full Text] [Related]
33. Association of paraoxonase activity and atherosclerosis in patients with chronic hepatitis B.
Karsen H; Binici I; Sunnetcioglu M; Baran AI; Ceylan MR; Selek S; Celik H
Afr Health Sci; 2012 Jun; 12(2):114-8. PubMed ID: 23056015
[TBL] [Abstract][Full Text] [Related]
34. Serum paraoxonase activity and oxidative stress and their relationship with obesity-related metabolic syndrome and non-alcoholic fatty liver disease in obese children and adolescents.
Torun E; Gökçe S; Ozgen İT; Aydın S; Cesur Y
J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):667-75. PubMed ID: 24706428
[TBL] [Abstract][Full Text] [Related]
35. Paraoxonase and arylesterase activity with oxidative status in children with thalassemia major.
Cakmak A; Soker M; Koc A; Erel O
J Pediatr Hematol Oncol; 2009 Aug; 31(8):583-7. PubMed ID: 19636263
[TBL] [Abstract][Full Text] [Related]
36. The influence of hemodialysis membrane permeability on serum paraoxonase-1 activity and oxidative status parameters.
Horoz M; Kiykim AA; Cimen B; Erdem A
Artif Organs; 2011 Oct; 35(10):923-9. PubMed ID: 21517907
[TBL] [Abstract][Full Text] [Related]
37. Assessment of paraoxonase activities in patients with knee osteoarthritis.
Soran N; Altindag O; Cakir H; Celik H; Demirkol A; Aksoy N
Redox Rep; 2008; 13(5):194-8. PubMed ID: 18796237
[TBL] [Abstract][Full Text] [Related]
38. Increased oxidative stress in normal-weight postmenopausal women with metabolic syndrome compared with metabolically healthy overweight/obese individuals.
Kim M; Paik JK; Kang R; Kim SY; Lee SH; Lee JH
Metabolism; 2013 Apr; 62(4):554-60. PubMed ID: 23142163
[TBL] [Abstract][Full Text] [Related]
39. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
[TBL] [Abstract][Full Text] [Related]
40. An evaluation of serum paraoxonase together with arylesterase activities and oxidative stress in children with intractable epilepsy: a cross-sectional study.
Calik M; Oguz E; Sarikaya S; Kocaturk O; Koca B; Gungor HE; Aksoy N; Yoldas TK; Iscan A
Epilepsy Res; 2014 Nov; 108(9):1591-6. PubMed ID: 25218892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
